| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |